Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Interventional Study Comparing Genotype-Guided Therapy Versus Usual Care to Prevent Severe Cutaneous Adverse Reactions Associated With Allopurinol and Carbamazepine in Vietnam

NCT07369622 is registered in ClinicalTrials.gov with Haiphong University of Medicine and Pharmacy as lead sponsor.

NCT NCT07369622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07369622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Interventional Study Comparing Genotype-Guided Therapy Versus Usual Care to Prevent Severe Cutaneous Adverse Reactions Associated With Allopurinol and Carbamazepine in Vietnam
Lead sponsor
Haiphong University of Medicine and Pharmacy
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 20, 2026
Completion date
December 30, 2028
Enrollment
228 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gout and hyperuricemia, gout arthritis, gout initiating urate-loweringurate-lowering therapy